AC
Athanor Capital Portfolio holdings
AUM
$24.6M
1-Year Return
2.48%
This Quarter Return
+11.82%
1 Year Return
+2.48%
3 Year Return
+113.29%
5 Year Return
+205.45%
10 Year Return
–
AUM
$2.18B
AUM Growth
+$502M
(+30%)
Cap. Flow
+$353M
Cap. Flow
% of AUM
16.23%
Top 10 Holdings %
Top 10 Hldgs %
28.83%
Holding
728
New
196
Increased
152
Reduced
133
Closed
206
Top Buys
| 1 |
Microsoft
MSFT
|
+$42.3M |
| 2 |
Verizon
VZ
|
+$39.2M |
| 3 |
NBL
Noble Energy, Inc.
NBL
|
+$33.6M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$33.5M |
| 5 |
Procter & Gamble
PG
|
+$30.8M |
Top Sells
Sector Composition
| 1 | Consumer Discretionary | 21.2% |
| 2 | Technology | 17.99% |
| 3 | Financials | 12.78% |
| 4 | Communication Services | 12.4% |
| 5 | Industrials | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCACU
401
DELISTED
Falcon Capital Acquisition Corp. Unit
FCACU
| $309K | 0.01% |
+30,000
| New | +$309K |
|
402
Black Diamond Therapeutics
BDTX
$185M
| $309K | 0.01% |
10,228
-7,568
| -43% | -$229K |
|
403
MacroGenics
MGNX
$111M
| $309K | 0.01% |
+12,263
| New | +$309K |
|
404
Synchrony
SYF
$28B
| $309K | 0.01% |
11,799
-7,444
| -39% | -$195K |
|
405
Protagonist Therapeutics
PTGX
$3.63B
| $306K | 0.01% |
+15,648
| New | +$306K |
|
406
Celldex Therapeutics
CLDX
$1.55B
| $305K | 0.01% |
+20,588
| New | +$305K |
|
407
Immunovant
IMVT
$2.86B
| $303K | 0.01% |
8,618
-7,710
| -47% | -$271K |
|
408
EPAM Systems
EPAM
$9.16B
| $302K | 0.01% |
+935
| New | +$302K |
|
409
Travere Therapeutics
TVTX
$1.93B
| $302K | 0.01% |
16,378
-8,022
| -33% | -$148K |
|
410
AvalonBay Communities
AVB
$27.8B
| $301K | 0.01% |
2,014
-2,345
| -54% | -$350K |
|
|
NXDT
411
NexPoint Diversified Real Estate Trust
NXDT
$176M
| $300K | 0.01% |
+34,699
| New | +$300K |
|
412
Stoke Therapeutics
STOK
$1.21B
| $299K | 0.01% |
8,930
-4,125
| -32% | -$138K |
|
413
CBRE Group
CBRE
$48.2B
| $298K | 0.01% |
+6,355
| New | +$298K |
|
414
Electronic Arts
EA
$41.5B
| $297K | 0.01% |
2,278
-2,272
| -50% | -$296K |
|
|
ATNX
415
DELISTED
Athenex, Inc. Common Stock
ATNX
| $297K | 0.01% |
1,227
-329
| -21% | -$79.6K |
|
|
NLSN
416
DELISTED
Nielsen Holdings plc
NLSN
| $296K | 0.01% |
+20,889
| New | +$296K |
|
417
Snap
SNAP
$12.3B
| $294K | 0.01% |
11,244
-26,181
| -70% | -$685K |
|
418
BlackLine
BL
$3.37B
| $290K | 0.01% |
+3,239
| New | +$290K |
|
419
Sangamo Therapeutics
SGMO
$157M
| $290K | 0.01% |
+30,681
| New | +$290K |
|
|
GOOS
420
Canada Goose Holdings
GOOS
$1.45B
| $288K | 0.01% |
+8,949
| New | +$288K |
|
421
Sherwin-Williams
SHW
$90.1B
| $284K | 0.01% |
+1,224
| New | +$284K |
|
422
Brinker International
EAT
$6.93B
| $280K | 0.01% |
+6,565
| New | +$280K |
|
423
M&T Bank
MTB
$31.1B
| $275K | 0.01% |
2,984
| – | – |
|
424
Alaska Air
ALK
$7.18B
| $272K | 0.01% |
7,439
-15,191
| -67% | -$555K |
|
425
Morningstar
MORN
$10.9B
| $272K | 0.01% |
1,691
| – | – |
|